995
Views
3
CrossRef citations to date
0
Altmetric
Editorial

How to improve the survival of the kidney transplant – is it only the pharmaceutical management?

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Goce Spasovski, Lada Trajceska & Irena Rambabova-Bushljetik. (2022) Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date. Expert Opinion on Pharmacotherapy 23:12, pages 1397-1412.
Read now

Articles from other publishers (2)

AK Bhalla, BT Anil Kumar, Munish Chauhan, Pratik Das, Bhupendra Gandhi, Umapati Hegde, Tarun Jeloka, Manish Mali, PranawKumar Jha, Ajay Kher, KamalKiran Mukkavilli, Raja Ramachandran & Vivekanand Jha. (2019) ABO-incompatible kidney transplantation: Indian working group recommendations. Indian Journal of Transplantation 13:4, pages 252.
Crossref
Oleg O. Rummo, Mario Carmellini, Lionel Rostaing, Rainer Oberbauer, Maarten H. L. Christiaans, Christiane Mousson, Robert M. Langer, Franco Citterio, Bernard Charpentier, Malcolm Brown, Gbenga Kazeem & Frank Lehner. (2017) ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus . Transplant International 30:1, pages 83-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.